| De novo proteins from designed combinatorial libraries MH Hecht, A Das, A Go, LH Bradley, Y Wei Protein science 13 (7), 1711-1723, 2004 | 267 | 2004 |
| Anti-inflammatory ω-3 endocannabinoid epoxides DR McDougle, JE Watson, AA Abdeen, R Adili, MP Caputo, JE Krapf, ... Proceedings of the National Academy of Sciences 114 (30), E6034-E6043, 2017 | 190 | 2017 |
| Screening of type I and II drug binding to human cytochrome P450-3A4 in nanodiscs by localized surface plasmon resonance spectroscopy A Das, J Zhao, GC Schatz, SG Sligar, RP Van Duyne Analytical chemistry 81 (10), 3754-3759, 2009 | 174 | 2009 |
| Resonance surface plasmon spectroscopy: low molecular weight substrate binding to cytochrome P450 J Zhao, A Das, X Zhang, GC Schatz, SG Sligar, RP Van Duyne Journal of the American Chemical Society 128 (34), 11004-11005, 2006 | 152 | 2006 |
| Integration of multi-omics data from mouse diversity panel highlights mitochondrial dysfunction in non-alcoholic fatty liver disease KC Krishnan, Z Kurt, R Barrere-Cain, S Sabir, A Das, R Floyd, L Vergnes, ... Cell systems 6 (1), 103-115. e7, 2018 | 144 | 2018 |
| Redox potential control by drug binding to cytochrome P450 3A4 A Das, YV Grinkova, SG Sligar Journal of the American Chemical Society 129 (45), 13778-13779, 2007 | 136 | 2007 |
| Optimizations to achieve high-level expression of cytochrome P450 proteins using Escherichia coli expression systems S Zelasko, A Palaria, A Das Protein expression and purification 92 (1), 77-87, 2013 | 134 | 2013 |
| Emerging class of omega-3 fatty acid endocannabinoids & their derivatives JE Watson, JS Kim, A Das Prostaglandins & other lipid mediators 143, 106337, 2019 | 117 | 2019 |
| Modulation of the cytochrome P450 reductase redox potential by the phospholipid bilayer A Das, SG Sligar Biochemistry 48 (51), 12104-12112, 2009 | 109 | 2009 |
| Recent advances in nanodisc technology for membrane protein studies (2012–2017) JE Rouck, JE Krapf, J Roy, HC Huff, A Das FEBS letters 591 (14), 2057-2088, 2017 | 108 | 2017 |
| Nanografting de novo proteins onto gold surfaces Y Hu, A Das, MH Hecht, G Scoles Langmuir 21 (20), 9103-9109, 2005 | 102 | 2005 |
| Comparative pharmacokinetics of Δ9-tetrahydrocannabinol in adolescent and adult male mice A Torrens, V Vozella, H Huff, B McNeil, F Ahmed, A Ghidini, SV Mahler, ... Journal of Pharmacology and Experimental Therapeutics 374 (1), 151-160, 2020 | 80 | 2020 |
| Endocannabinoid metabolism by cytochrome P450 monooxygenases S Zelasko, WR Arnold, A Das Prostaglandins & other lipid mediators 116, 112-123, 2015 | 80 | 2015 |
| Endocannabinoids anandamide and 2-arachidonoylglycerol are substrates for human CYP2J2 epoxygenase DR McDougle, A Kambalyal, DD Meling, A Das Journal of Pharmacology and Experimental Therapeutics 351 (3), 616-627, 2014 | 68 | 2014 |
| Resonance localized surface plasmon spectroscopy: Sensing substrate and inhibitor binding to cytochrome P450 J Zhao, A Das, GC Schatz, SG Sligar, RP Van Duyne The Journal of Physical Chemistry C 112 (34), 13084-13088, 2008 | 67 | 2008 |
| Peroxidase activity of de novo heme proteins immobilized on electrodes A Das, MH Hecht Journal of inorganic biochemistry 101 (11-12), 1820-1826, 2007 | 54 | 2007 |
| Functional studies of N‐terminally modified CYP2J2 epoxygenase in model lipid bilayers DR McDougle, A Palaria, E Magnetta, DD Meling, A Das Protein Science 22 (7), 964-979, 2013 | 53 | 2013 |
| Cross-talk of cannabinoid and endocannabinoid metabolism is mediated via human cardiac CYP2J2 WR Arnold, AT Weigle, A Das Journal of inorganic biochemistry 184, 88-99, 2018 | 49 | 2018 |
| Nanomechanical detection of cholera toxin using microcantilevers functionalized with ganglioside nanodiscs SH Tark, A Das, S Sligar, VP Dravid Nanotechnology 21, 435502, 2010 | 48 | 2010 |
| An Activity‐Based Sensing Approach for the Detection of Cyclooxygenase‐2 in Live Cells AK Yadav, CJ Reinhardt, AS Arango, HC Huff, L Dong, MG Malkowski, ... Angewandte Chemie 132 (8), 3333-3340, 2020 | 47 | 2020 |
Stephen SligarProfessor, University of Illinoisillinois.edu의 이메일 확인됨
